These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 27617199)

  • 21. The Gut Commensal Escherichia coli Aggravates High-Fat-Diet-Induced Obesity and Insulin Resistance in Mice.
    Ju T; Bourrie BCT; Forgie AJ; Pepin DM; Tollenaar S; Sergi CM; Willing BP
    Appl Environ Microbiol; 2023 Mar; 89(3):e0162822. PubMed ID: 36809030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice.
    Balakumar M; Prabhu D; Sathishkumar C; Prabu P; Rokana N; Kumar R; Raghavan S; Soundarajan A; Grover S; Batish VK; Mohan V; Balasubramanyam M
    Eur J Nutr; 2018 Feb; 57(1):279-295. PubMed ID: 27757592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roux-en-Y Gastric Bypass Improved Insulin Resistance via Alteration of the Human Gut Microbiome and Alleviation of Endotoxemia.
    Shi Q; Wang Q; Zhong H; Li D; Yu S; Yang H; Wang C; Yin Z
    Biomed Res Int; 2021; 2021():5554991. PubMed ID: 34337024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucoraphanin: a broccoli sprout extract that ameliorates obesity-induced inflammation and insulin resistance.
    Xu L; Nagata N; Ota T
    Adipocyte; 2018; 7(3):218-225. PubMed ID: 29898626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ectopic lipid accumulation: A potential cause for metabolic disturbances and a contributor to the alteration of kidney function.
    Guebre-Egziabher F; Alix PM; Koppe L; Pelletier CC; Kalbacher E; Fouque D; Soulage CO
    Biochimie; 2013 Nov; 95(11):1971-9. PubMed ID: 23896376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD.
    Larabi A; Barnich N; Nguyen HTT
    Autophagy; 2020 Jan; 16(1):38-51. PubMed ID: 31286804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-C motif chemokine receptor 9 regulates obesity-induced insulin resistance via inflammation of the small intestine in mice.
    Amiya T; Nakamoto N; Irie J; Taniki N; Chu PS; Koda Y; Miyamoto K; Yamaguchi A; Shiba S; Morikawa R; Itoh H; Kanai T
    Diabetologia; 2021 Mar; 64(3):603-617. PubMed ID: 33399911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arctigenin ameliorates high-fat diet-induced metabolic disorders by reshaping gut microbiota and modulating GPR/HDAC3 and TLR4/NF-κB pathways.
    Wang N; Li C; Zhang Z
    Phytomedicine; 2024 Oct; 135():156123. PubMed ID: 39396403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
    Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
    Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time.
    de Groot P; Scheithauer T; Bakker GJ; Prodan A; Levin E; Khan MT; Herrema H; Ackermans M; Serlie MJM; de Brauw M; Levels JHM; Sales A; Gerdes VE; Ståhlman M; Schimmel AWM; Dallinga-Thie G; Bergman JJ; Holleman F; Hoekstra JBL; Groen A; Bäckhed F; Nieuwdorp M
    Gut; 2020 Mar; 69(3):502-512. PubMed ID: 31147381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbiota dysbiosis caused by dietetic patterns as a promoter of Alzheimer's disease through metabolic syndrome mechanisms.
    Navalón-Monllor V; Soriano-Romaní L; Silva M; de Las Hazas ML; Hernando-Quintana N; Suárez Diéguez T; Esteve PM; Nieto JA
    Food Funct; 2023 Aug; 14(16):7317-7334. PubMed ID: 37470232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional Fiber Reduces Mice Obesity by Regulating Intestinal Microbiota.
    Zhang M; Liu J; Li C; Gao J; Xu C; Wu X; Xu T; Cui C; Wei H; Peng J; Zheng R
    Nutrients; 2022 Jun; 14(13):. PubMed ID: 35807856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clean-DM1, a Korean Polyherbal Formula, Improves High Fat Diet-Induced Diabetic Symptoms in Mice by Regulating IRS/PI3K/AKT and AMPK Expressions in Pancreas and Liver Tissues.
    Wang P; Liu Y; Kang SY; Lyu C; Han X; Ho T; Lee KJ; Meng X; Park YK; Jung HW
    Chin J Integr Med; 2024 Feb; 30(2):125-134. PubMed ID: 37118530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice.
    Carvalho BM; Guadagnini D; Tsukumo DML; Schenka AA; Latuf-Filho P; Vassallo J; Dias JC; Kubota LT; Carvalheira JBC; Saad MJA
    Diabetologia; 2012 Oct; 55(10):2823-2834. PubMed ID: 22828956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consistent gut bacterial and short-chain fatty acid signatures in hypoabsorptive bariatric surgeries correlate with metabolic benefits in rats.
    Mukorako P; Lemoine N; Biertho L; Lebel S; Roy MC; Plamondon J; Tchernof A; Varin TV; Anhê FF; St-Pierre DH; Marette A; Richard D
    Int J Obes (Lond); 2022 Feb; 46(2):297-306. PubMed ID: 34686781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletion of intestinal epithelial AMP-activated protein kinase alters distal colon permeability but not glucose homeostasis.
    Olivier S; Pochard C; Diounou H; Castillo V; Divoux J; Alcantara J; Leclerc J; Guilmeau S; Huet C; Charifi W; Varin TV; Daniel N; Foretz M; Neunlist M; Salomon BL; Ghosh P; Marette A; Rolli-Derkinderen M; Viollet B
    Mol Metab; 2021 May; 47():101183. PubMed ID: 33548500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota.
    Wang Y; Liu H; Zheng M; Yang Y; Ren H; Kong Y; Wang S; Wang J; Jiang Y; Yang J; Shan C
    Front Endocrinol (Lausanne); 2021; 12():609134. PubMed ID: 34025574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined loss of GLP-1R and Y2R does not alter progression of high-fat diet-induced obesity or response to RYGB surgery in mice.
    Boland BB; Mumphrey MB; Hao Z; Townsend RL; Gill B; Oldham S; Will S; Morrison CD; Yu S; Münzberg H; Rhodes CJ; Trevaskis JL; Berthoud HR
    Mol Metab; 2019 Jul; 25():64-72. PubMed ID: 31126840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.